Recruiting × Urinary Bladder Neoplasms × Gynecologic × Clear all The Vanguard Study: Testing a New Way to Screen for Cancer
Phase NA Recruiting
24,000 enrolled
panSOHO
Phase 2 Recruiting
111 enrolled
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Phase 1 Recruiting
1,006 enrolled
DP-04
Recruiting
100 enrolled
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Phase 2 Recruiting
320 enrolled
(CLOCS-2)
Recruiting
2,900 enrolled
NEXUS-01
Phase 1 Recruiting
420 enrolled
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
Phase 2 Recruiting
148 enrolled
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Phase 1 Recruiting
258 enrolled
IDOV-Immune for Advanced Solid Tumors
Phase 1 Recruiting
78 enrolled
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Phase 1 Recruiting
240 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
IT-TCP POS
Phase NA Recruiting
300 enrolled
GUARDIAN-101
Phase 1 Recruiting
90 enrolled
Improving Care for Rural Patients With Solid Tumors
Phase NA Recruiting
320 enrolled
A Study of MGC026 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
250 enrolled
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 2 Recruiting
740 enrolled
iCaRe2
Recruiting
999,999 enrolled
CAMPERR
Recruiting
7,000 enrolled
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
Phase NA Recruiting
50 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
ELEPHAS-02
Recruiting
416 enrolled
ON-5001
Phase 1 Recruiting
168 enrolled
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase 2 Recruiting
27 enrolled
Image-Guided Gynecologic Brachytherapy
Phase NA Recruiting
54 enrolled
Trop2-targeted immunoPET Imaging of Solid Tumors
Phase 2/3 Recruiting
400 enrolled
DETERMINE
Phase 2/3 Recruiting
30 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
RABBIT
Phase 1/2 Recruiting
30 enrolled
OvAR-Y
Recruiting
10 enrolled
ORACLE
Recruiting
2,020 enrolled
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Phase 1 Recruiting
30 enrolled
FASCINATE
Phase NA Recruiting
100 enrolled
TTBF
Phase NA Recruiting
1,000 enrolled
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors
Phase 1 Recruiting
241 enrolled
ABILITY-1
Phase 1/2 Recruiting
115 enrolled
START-001
Phase 1/2 Recruiting
365 enrolled
HTL0039732 in Participants With Advanced Solid Tumours
Phase 1/2 Recruiting
150 enrolled
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
Phase 1 Recruiting
12 enrolled
Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors
Phase 1 Recruiting
12 enrolled
INSPIRE
Recruiting
5,350 enrolled
CER
Recruiting
15,000 enrolled
ART-02
Recruiting
649 enrolled
ONCOPRO
Phase NA Recruiting
410 enrolled